<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51">
 <label>51.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>YW</given-names>
   </name>
   <name>
    <surname>Yiu</surname>
    <given-names>C-PB</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>K-Y</given-names>
   </name>
  </person-group>. 
  <article-title>Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates</article-title>. 
  <source>F1000Research</source>. (
  <year>2020</year>) 
  <volume>9</volume>:
  <fpage>129</fpage>. 
  <pub-id pub-id-type="doi">10.12688/f1000research.22457.1</pub-id>
  <?supplied-pmid 32194944?>
  <pub-id pub-id-type="pmid">32194944</pub-id>
 </mixed-citation>
</ref>
